These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 25524664
1. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas. Wobser M, Roth S, Reinartz T, Rosenwald A, Goebeler M, Geissinger E. Br J Dermatol; 2015 Jun; 172(6):1573-1580. PubMed ID: 25524664 [Abstract] [Full Text] [Related]
2. Indolent CD8-positive lymphoid proliferation of acral sites: identifying the sheep in wolf's clothing. Goodlad JR. Br J Dermatol; 2015 Jun; 172(6):1480-1481. PubMed ID: 26036157 [No Abstract] [Full Text] [Related]
3. Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder. Wobser M, Appenzeller S, Roth S, Siedel C, Goebeler M, Geissinger E, Rosenwald A, Maurus K. Br J Dermatol; 2024 Oct 17; 191(5):816-822. PubMed ID: 38924750 [Abstract] [Full Text] [Related]
4. Extrafacial indolent CD8-positive cutaneous lymphoid proliferation with unusual symmetrical presentation involving both feet. Wobser M, Petrella T, Kneitz H, Kerstan A, Goebeler M, Rosenwald A, Geissinger E. J Cutan Pathol; 2013 Nov 17; 40(11):955-61. PubMed ID: 24102688 [Abstract] [Full Text] [Related]
5. Correspondence article regarding CD68 as a marker of CD8+ lymphoid proliferation suggested by Wobser et al. Lecamwasam K, Mathew B, Gilson D, Burton C, Laws P. Br J Dermatol; 2016 May 17; 174(5):1158-9. PubMed ID: 26801738 [No Abstract] [Full Text] [Related]
6. Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases. Wobser M, Reinartz T, Roth S, Goebeler M, Rosenwald A, Geissinger E. Oncol Ther; 2016 May 17; 4(2):199-210. PubMed ID: 28261650 [Abstract] [Full Text] [Related]
8. Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient. Kluk J, Kai A, Koch D, Taibjee SM, O'Connor S, Persic M, Morris S, Whittaker S, Cerroni L, Kempf W, Petrella T, Robson A. J Cutan Pathol; 2016 Feb 17; 43(2):125-36. PubMed ID: 26423705 [Abstract] [Full Text] [Related]
9. Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop. Kempf W, Petrella T, Willemze R, Jansen P, Berti E, Santucci M, Geissinger E, Cerroni L, Maubec E, Battistella M, Goodlad J, Guenova E, Lappalainen K, Ranki A, Craig P, Calonje E, Martin B, Whittaker S, Oschlies I, Wehkamp U, Nicolay JP, Wobser M, Scarisbruck J, Pimpinelli N, Stadler R, Kerl French K, Quaglino P, Lin J, Chen L, Beer M, Emanuel P, Dalle S, Robson A. Br J Dermatol; 2022 May 17; 186(5):887-897. PubMed ID: 34988968 [Abstract] [Full Text] [Related]
10. Atypical BCL6/GATA3+ Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma: A Diagnostic Challenge. Prieto-Torres L, Camacho-García D, Piris MÁ, Requena L, Rodríguez-Pinilla SM. Am J Dermatopathol; 2021 Feb 01; 43(2):137-140. PubMed ID: 32675470 [Abstract] [Full Text] [Related]
11. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Am J Pathol; 1999 Aug 01; 155(2):483-92. PubMed ID: 10433941 [Abstract] [Full Text] [Related]
12. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma? Gomez Vazquez M, Navarra Amayuelas R. Dermatol Online J; 2012 Mar 15; 18(3):11. PubMed ID: 22483522 [Abstract] [Full Text] [Related]
13. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment. Geller S, Hollmann TJ, Horwitz SM, Myskowski PL, Pulitzer M. Histopathology; 2020 Jan 15; 76(2):222-232. PubMed ID: 31355940 [Abstract] [Full Text] [Related]
14. Cutaneous Lymphomas with Cytotoxic Phenotype. García-Herrera A, Calonje E. Surg Pathol Clin; 2017 Jun 15; 10(2):409-427. PubMed ID: 28477889 [Abstract] [Full Text] [Related]
15. Primary Cutaneous CD8+ T-cell Lymphoma, an Indolent and Locally Aggressive Form Mimicking Paronychia. Beggs SM, Friedman BJ, Kornreich D, Okon L, Alpdogan O, Shi W, Sahu J. Am J Dermatopathol; 2018 Apr 15; 40(4):e52-e56. PubMed ID: 28984695 [Abstract] [Full Text] [Related]
16. Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma? Beltraminelli H, Müllegger R, Cerroni L. J Cutan Pathol; 2010 Jan 15; 37(1):81-4. PubMed ID: 19602068 [Abstract] [Full Text] [Related]
17. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells. Zhang L, Shao H. J Cutan Pathol; 2013 Aug 15; 40(8):720-4. PubMed ID: 23672694 [Abstract] [Full Text] [Related]
18. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement. Introcaso CE, Kim EJ, Gardner J, Junkins-Hopkins JM, Vittorio CC, Rook AH. Arch Dermatol; 2008 Aug 15; 144(8):1027-9. PubMed ID: 18711076 [Abstract] [Full Text] [Related]
19. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype. Yoshizawa N, Yagi H, Horibe T, Takigawa M, Sugiura M. Eur J Dermatol; 2007 Aug 15; 17(5):441-2. PubMed ID: 17673391 [Abstract] [Full Text] [Related]
20. A review of the solitary cutaneous T-cell lymphomas. Ally MS, Robson A. J Cutan Pathol; 2014 Sep 15; 41(9):703-14. PubMed ID: 24666254 [Abstract] [Full Text] [Related] Page: [Next] [New Search]